Home Latest News India Plans Incentives for Diabetes and Obesity Drug Manufacturers in 2026, Confirms Government Official
Latest NewsPharma

India Plans Incentives for Diabetes and Obesity Drug Manufacturers in 2026, Confirms Government Official

Share
Pills
Pills
Share

India is planning to give incentives to companies that will produce GLP-1 drugs locally in 2026. These drugs are used to treat diabetes and obesity. A top government official shared this news on Friday.

GLP-1 drugs, which were initially approved for treating diabetes, are now also used to help with obesity. They work by slowing down digestion, making patients feel full for a longer time.

Currently, Danish drugmaker Novo Nordisk holds the patent for semaglutide, a key ingredient in popular drugs like Wegovy (for obesity) and Ozempic (for diabetes). However, this patent will expire in India in 2026, according to industry experts.

“The (Indian) companies (planning) manufacturing GLP-1 drugs have applied for the government’s production-linked incentive (PLI) scheme,” said Arunish Chawla, Secretary of the Department of Pharmaceuticals, to Reuters. He added, “Once they start manufacturing in 2026 after patent expiries, we will give them the incentive,” without naming the companies involved.

Drugmakers worldwide are eager to enter the market for weight-loss drugs, which could reach a value of $100 billion by the end of the decade. In India, obesity rates are high, particularly among women, and the country has the second-highest number of people with type 2 diabetes. The World Obesity Federation Atlas predicts that around 11% of Indian adults will be obese by 2035.

Several domestic drug companies, including Biocon, Sun Pharma, Cipla, Dr. Reddy’s, and Lupin, are interested in this opportunity. However, they were not available for comments on Friday.

Since 2020, India has been offering incentives to boost local manufacturing in various sectors, including electronic products and drones, with mixed success. The companies that will receive incentives for GLP-1 drug production have listed their drugs as ‘anti-diabetic’ in their applications.

“Their usage for obesity will depend on necessary approvals at that time from the drug regulator,” Chawla noted.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as infections continue to spread across parts of Central and East Africa....

WHO
Health TipsInternational NewsLatest NewsLifestyle & WellnessWHO

WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know

More than 100 years after the discovery of insulin, millions of people living with type 1 diabetes continue to face challenges in accessing...

Breast Cancer
Health NewsOncology

Mammogram vs Ultrasound vs MRI: Which Breast Cancer Screening Test Is Right for You?

Breast cancer is one of the most common cancers affecting women worldwide, and early detection plays an important role in improving treatment outcomes....

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Section title

Related Articles
Breaking NewsPharmaPharma

India’s Robotic Surgery Revolution: How SSI Mantra Is Advancing Complex Heart Procedures

India’s latest breakthrough in robotic cardiac surgery has brought renewed attention to...

Latest NewsWHO

WHO Releases First-Ever Guidelines For Type 1 Diabetes In Adults: 5 Key Recommendations Explained

The World Health Organization (WHO) has issued its first-ever guidelines for the...

Health NewsLatest NewsLifestyle

7 Simple Ways to Protect Yourself from Air Pollution

Air pollution has become a major health concern today. Dust from construction...